PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Jul 2, 2024 FORM 8-K
EFFECT Jul 1, 2024
CORRESP Jun 27, 2024
8-K Jun 21, 2024 FORM 8-K
4 Jun 11, 2024
4 Jun 10, 2024
8-K May 28, 2024 CURRENT REPORT
UPLOAD May 24, 2024
S-3 May 20, 2024 FORM S-3
RW May 20, 2024 FORM RW
S-1 May 17, 2024 S-3
424B5 May 17, 2024 PROSPECTUS
8-K May 17, 2024 FORM 8-K
8-K May 9, 2024 CURRENT REPORT
10-Q May 9, 2024 FORM 10-Q FOR 3/31/24
DEFA14A May 8, 2024 FORM DEFA14A
DEF 14A May 8, 2024 DEFINITIVE PROXY STATEMENT
ARS May 8, 2024 ANNUAL REPORT TO SECURITY HOLDERS
PRE 14A Apr 22, 2024 PRELIMINARY PROXY STATEMENT
8-K Apr 2, 2024 CURRENT REPORT
10-K Apr 1, 2024 10-K FOR 12/31/23
4 Mar 5, 2024
4 Feb 27, 2024
4 Feb 22, 2024
4 Feb 20, 2024
← Newer Page 7 of 36 · 884 filings Older →